NCT04360343

Compare the Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of LC51-0255 Film-coated Tablet (SG85) With LC51-0255 Uncoated Tablet (SG82) in Healthy Subjects

A Randomized, Open-label, Single Dose, 2-period, 2-sequence, 2-treatment, Crossover Study to Compare the Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of LC51-0255 Film-coated Tablet (SG85) With LC51-0255 Uncoated Tablet (SG82) in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: LG Chem · Industry
• Sex: All
• Age: 19 Years – 45 Years
• Healthy volunteers: Accepted

Summary

To compare the pharmacokinetics, pharmacodynamics and safety/tolerability of LC51-0255 film-coated tablet (SG85) with LC51-0255 uncoated tablet (SG82) in healthy subjects.

Conditions

• Ulcerative Colitis

Interventions

Type	Name	Description
DRUG	Film-coated tablet	uncoated tablet

Timeline

• Start date: 2020-07-01
• Primary completion: 2020-10-01
• Completion: 2020-12-01
• First posted: 2020-04-24
• Last updated: 2021-01-22

Locations

1 site across 1 country: South Korea

Regulatory

• FDA-regulated drug study